Somatostatin analogs and intermediates thereto
US4061626A · kind A · utility
7Cited by
7References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 29, 1976 |
| Grant date | Dec 6, 1977 |
| Priority date | — |
| Expiry date | Apr 29, 1996 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The tetradecapeptides ##STR1## in which Y is Gly or D-Ala are described along with corresponding non-toxic pharmaceutically-acceptable acid addition salts as well as intermediates useful in the synthesis of the tetradecapeptides. The tetradecapeptide in which Y is Gly as well as its pharmaceutically acceptable acid addition salts exhibit as their principal activity the in vivo inhibition of the release of gastric acid. The tetradecapeptide in which Y is D-Ala as well as its pharmaceutically acceptable acid addition salts exhibit as their principal activity the in vivo stimulation of the release of growth hormone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.